The five-year diagnostic gap that one patient experienced with hidradenitis suppurativa—a condition he initially mistook for regular acne on his inner thighs—is not uncommon. Many people with this chronic skin disease spend years cycling through dermatologists, trying standard acne treatments, and growing increasingly frustrated before finally getting the correct diagnosis. His case underscores a critical gap in awareness: hidradenitis suppurativa (HS), also known as acne inversa, is often misidentified as ordinary acne, folliculitis, or even an infection that just won’t clear up, leading to years of ineffective treatment and unnecessary suffering.
Hidradenitis suppurativa is a painful, long-term inflammatory condition that primarily affects areas of skin where there is friction and where sweat glands concentrate—the underarms, groin, inner thighs, and buttocks. Unlike typical acne, which forms on the face, chest, and back from clogged pores and bacteria, HS involves deeper inflammation of the hair follicles and surrounding tissues, often progressing to painful nodules, abscesses, and scarring. The five-year delay this patient experienced wasn’t due to laziness or lack of medical care; it was the result of a condition that simply looks confusing under the skin and presents with symptoms that overlap with several other more common skin diseases. Understanding why diagnosis takes so long—and what sets hidradenitis suppurativa apart from acne—is essential for anyone who suspects they might have this condition or who has struggled with unexplained skin issues in sensitive areas.
Table of Contents
- Why Does Hidradenitis Suppurativa Get Misdiagnosed as Acne for Years?
- How Hidradenitis Suppurativa Differs from Common Acne
- The Journey to Diagnosis: Why Five Years Is Not Unusual
- Getting the Right Diagnosis: Tests, Biopsies, and What to Expect
- Treatment Options and the Challenge of Managing a Chronic Disease
- Surgical Interventions and When They Become Necessary
- Living with Hidradenitis Suppurativa: Long-Term Outlook and Quality of Life
- Conclusion
Why Does Hidradenitis Suppurativa Get Misdiagnosed as Acne for Years?
The visual overlap between acne and hidradenitis suppurativa can be striking, especially in early stages. Both conditions produce pustules, nodules, and sometimes discharge. Both can be painful and leave marks or scars. A patient with HS lesions on their inner thighs might see bumps that look inflamed and infected, the same way acne appears on the face. Without a full picture of the patient’s medical history, the location of lesions, and the pattern of recurrence, it’s easy for a primary care doctor or even an early-stage dermatology visit to misattribute these symptoms to acne and prescribe standard acne treatments—oral antibiotics, topical retinoids, benzoyl peroxide, or isotretinoin. The problem deepens when these standard acne treatments fail to work. Many patients like the one in this case go through multiple rounds of antibiotics—sometimes for months or even years—without seeing improvement.
They may start oral birth control (if female) to regulate hormones, switch dermatologists when one approach doesn’t work, or be told that their acne is simply “resistant” to treatment. The frustration mounts because the real disease process is entirely different: HS is driven by abnormalities in the immune system and the structure of hair follicles in specific body areas, not by the same mechanisms as typical acne. Standard acne treatments, therefore, don’t address the root problem. The locations where HS typically appears—the groin, armpits, and areas between the buttocks—are also places where many people feel embarrassed or reluctant to describe symptoms in detail to their doctors. This communication gap further delays diagnosis. A patient might mention “a skin problem down there” without fully explaining the recurrence, the extent of scarring, or the way lesions seem to cluster in one area. The doctor, not hearing the full picture, defaults to the most common diagnosis: acne.
How Hidradenitis Suppurativa Differs from Common Acne
The distinguishing features of hidradenitis suppurativa become clearer once you know what to look for. HS typically appears only in areas of friction and moisture—the inframammary fold (under the breasts), the groin, the inguinal creases (inner thighs), the perianal region, and the axillae (armpits). Acne, by contrast, can appear anywhere on the body but most commonly on the face, chest, upper back, and shoulders. If your bumps are exclusively in one of these friction zones and never appear on your face or chest, that’s a red flag pointing toward HS rather than acne. The lesions themselves behave differently over time. With acne, pustules typically come to a head, drain, and heal within days to a couple of weeks. With HS, lesions often persist for weeks or months, may repeatedly drain and refill, and frequently progress to larger, deeper nodules and abscesses.
Scarring in HS is also distinctly more severe—patients often develop ropelike scars (called sinus tracts) that burrow under the skin, connecting separate lesions. This scarring pattern is not typical of acne scarring, which tends to be more superficial and varied in appearance. A crucial limitation to remember: even dermatologists sometimes need to do a skin biopsy or use imaging to definitively confirm HS, especially in early stages, because the appearance alone can be ambiguous. Another key difference lies in the course of the disease. Acne often improves with age, particularly after the teenage years, and responds predictably to standard treatments. HS, by contrast, is a chronic disease that typically worsens over time without appropriate treatment, often flaring unpredictably and sometimes improving only temporarily. The inflammation in HS can be severe enough to restrict movement—a patient with HS in the groin area might find it painful to walk, exercise, or wear tight clothing. This functional impact is rarely seen with typical acne.
The Journey to Diagnosis: Why Five Years Is Not Unusual
The patient’s five-year diagnostic odyssey reflects a broader pattern in the medical experience of hidradenitis suppurativa. Many people spend years bouncing between healthcare providers before someone finally connects the dots. The journey often follows a similar arc: initial presentation at a primary care doctor or dermatologist, treatment for presumed acne, months of follow-ups and medication adjustments, increasing frustration, and then, usually by accident or because the patient finally sees a dermatologist with HS expertise, the correct diagnosis. What makes this delay so consequential is that early, aggressive treatment of HS can slow or even halt the disease’s progression, while years of untreated HS lead to cumulative scarring, more severe infections, and a worse prognosis.
Some patients spend those years developing moderate to severe HS while being told they just need to wait out their acne or try yet another antibiotic. The psychological burden is equally significant: the frustration of having a painful, chronic disease that no one seems to understand, combined with the stigma of lesions in intimate areas, can lead to depression, social withdrawal, and diminished quality of life. The moment of diagnosis, when it finally comes, often brings both relief and anger. Relief because the patient’s symptoms finally make sense, and anger because they realize how much time was lost—time during which the condition could have been better managed with appropriate treatment and lifestyle adjustments.
Getting the Right Diagnosis: Tests, Biopsies, and What to Expect
If you suspect you might have hidradenitis suppurativa, the diagnostic process typically begins with a detailed clinical evaluation by a dermatologist, ideally one with experience treating HS. There is no single blood test or imaging study that definitively diagnoses HS; instead, the diagnosis is based on clinical features, the pattern of lesions, and sometimes a skin biopsy. A dermatologist will examine the affected areas, ask detailed questions about how long you’ve had lesions, whether they drain, and whether there’s scarring, and compare these findings against diagnostic criteria (such as the European, American, and Canadian consensus guidelines). A skin biopsy—removing a small sample of tissue from an affected area and examining it under a microscope—may be ordered if the diagnosis is unclear. The biopsy can rule out other conditions (like folliculitis, acne, or cancer) and confirm the characteristic histology of HS: inflammation of the hair follicle and surrounding tissue, sometimes with sinus tracts and fibrosis.
This is not a painful procedure—the skin is numbed first, a small punch is taken, and the area is stitched closed. Imaging studies like ultrasound or MRI might also be used to assess the extent and depth of disease, especially if you have multiple areas affected or significant scarring. A limitation worth noting: HS is often underdiagnosed even among dermatologists, particularly those who don’t specialize in this condition. If your first dermatology consultation doesn’t lead to an HS diagnosis but the clinical picture seems consistent, seeking a second opinion from a dermatologist who explicitly lists HS or inflammatory skin diseases as an area of expertise is reasonable and often worthwhile. Some patients have benefited from seeing a specialist at an academic medical center or a dermatologist who participates in HS research or support networks.
Treatment Options and the Challenge of Managing a Chronic Disease
Once hidradenitis suppurativa is correctly diagnosed, the treatment approach shifts dramatically from standard acne care. Early-stage HS may be managed with topical antibiotics (like clindamycin) and antiseptic washes, combined with lifestyle modifications: wearing loose, breathable clothing, using antiperspirants to reduce sweating, avoiding tight undergarments, and keeping the affected areas clean and dry. However, many cases progress to moderate or severe HS, which requires systemic treatment. Oral antibiotics—particularly clindamycin combined with rifampicin—are often a first-line systemic therapy, though the rationale is somewhat different from treating acne: the goal is to reduce bacterial overgrowth and inflammation, not necessarily to eliminate acne-causing bacteria. Hormone therapy may help some women with HS.
Biological therapies, particularly TNF-alpha inhibitors like infliximab or adalimumab, have shown remarkable effectiveness in many patients, sometimes producing significant remission of lesions and reduction in pain. However, biological therapies are expensive, require regular monitoring, and come with their own set of potential side effects and risks. A critical warning: untreated or inadequately treated HS can lead to serious complications, including recurrent skin infections, formation of abscesses that may require drainage, and progressive scarring that can eventually restrict movement or even require surgical intervention. In rare cases, chronic HS can increase the risk of squamous cell carcinoma in the affected skin. These aren’t possibilities to ignore; they’re reasons why prompt, accurate diagnosis and appropriate treatment matter so much. The tradeoff many patients face is between living with chronic pain and limited mobility while avoiding systemic medications, or accepting the side effects and risks of more aggressive treatments to preserve function and prevent long-term damage.
Surgical Interventions and When They Become Necessary
For patients with severe, localized HS that hasn’t responded to medical management, or for those with extensive scarring and sinus tracts, surgical options exist. These range from simple drainage of acute abscesses under local anesthesia to more extensive surgical excision of affected skin and tissue. Wide local excision—removing the diseased area along with a margin of normal-looking skin—can sometimes provide long-term remission in that specific area, though HS can recur in the same location or spread to nearby areas. A real example: a patient with severe HS limited to one armpit might undergo surgical excision of all the affected tissue, with or without skin grafting to close the wound.
If the surgery is successful and combined with ongoing medical management, that patient might achieve years of remission in that location. However, surgery is not a cure for hidradenitis suppurativa as a whole disease; it’s a regional treatment. Many patients require multiple surgeries over their lifetime as the disease worsens or spreads to new areas. Surgery also carries risks—infection, delayed wound healing, recurrence, and the physical and emotional challenges of recovery from a significant surgical procedure in an intimate or sensitive body area.
Living with Hidradenitis Suppurativa: Long-Term Outlook and Quality of Life
The long-term outlook for hidradenitis suppurativa varies widely, depending on the severity of disease at diagnosis, how quickly and accurately it’s treated, individual response to therapies, and adherence to lifestyle modifications and treatment regimens. Some patients achieve sustained remission with appropriate treatment. Others experience a chronic, unpredictable course with periods of flaring and relative quiescence. A few experience progressive disease that becomes increasingly difficult to manage and increasingly limiting to daily life.
The psychological and social dimensions of living with HS deserve attention. The pain, scarring, and location of lesions (often in areas associated with sexuality and bodily privacy) can profoundly affect self-image, intimate relationships, and mental health. Patients with HS report higher rates of depression and anxiety than the general population. Awareness and advocacy within the medical and patient communities are slowly improving, with HS support groups, educational resources, and patient networks now more accessible than they were even a decade ago. Connecting with others who have HS—whether through in-person support groups, online communities, or HS-focused organizations—can be tremendously validating and can provide practical tips for managing the disease and navigating the healthcare system.
Conclusion
The five-year diagnostic delay experienced by this patient, while frustrating, is a reminder of a broader systemic issue: hidradenitis suppurativa is underrecognized, often misattributed to acne or other conditions, and poorly understood even among some dermatologists. However, awareness is growing. More dermatologists are becoming familiar with HS. More patients are learning to advocate for themselves and seek the specialized care they need.
If you have recurrent, painful lesions in areas of friction and moisture—the armpits, groin, inner thighs, or buttocks—and standard acne treatments have not helped, asking specifically about hidradenitis suppurativa is justified and important. The key to better outcomes is early, accurate diagnosis and prompt initiation of appropriate treatment. If you suspect HS, seek evaluation from a dermatologist, and if the initial evaluation doesn’t feel satisfactory, don’t hesitate to seek a second opinion from a specialist with HS expertise. The difference between years of ineffective treatment and years of effective management can come down to a single conversation with a doctor who knows what to listen for and what to look for. You deserve that clarity and that care.
